The Effects of Modafinil Treatment on Neuropsychological and Attentional Bias Performance During 7-Day Inpatient Withdrawal From Methamphetamine Dependence

Experimental and Clinical Psychopharmacology

Volumn 18, Issue 6, 2010, Pages 489-497

  Hester, Robert ^a   Lee, Nicole ^a   Pennay, Amy ^a   Nielsen, Suzi ^b   Ferris, Jason ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Attentional bias; Emotional Stroop; Methamphetamine; Modafinil; Neuropsychological performance

Indexed keywords

METHAMPHETAMINE; MODAFINIL; PLACEBO;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFECT; EMOTION; FEMALE; FOLLOW UP; HUMAN; LEARNING; METHAMPHETAMINE DEPENDENCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RECALL; RELAPSE; SPEECH; STIMULUS RESPONSE; STROOP TEST; TASK PERFORMANCE; VERBAL FLUENCY; VERBAL MEMORY; VISUAL MEMORY;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY; METHAMPHETAMINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; RECURRENCE; STROOP TEST; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650983958     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0021791     Document Type: Article

References (72)

1. Australian Institute of Health and Welfare. (2007). Alcohol and other drug treatment services in Australia 2005-6: Report on the National Minimum Data Set. Drug Treatment Series No 7. Canberra: AIHW.
2. Australian Institute of Health and Welfare. National drug strategy household survey 2007: First results. Drug statistics series number 20. Cat. no. PHE 98. Canberra: AIHW 2008.
3. Anderson A.L., Reid M.S., Li S.H., Holmes T., Shemanski L., Slee A., Smith E.V., et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence 2009, 104:133-139.
4. Bradley B., Field M., Mogg K., De Houwer J. Attentional and evaluative biases for smoking cues in nicotine dependence: Component processes of biases in visual orienting. Behavioural Pharmacology 2004, 15:29-36.
5. Carpenter K.M., Schreiber E., Church S., McDowell D. Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addictive Behaviors 2005, 31:174-181.
6. Cherner M., Suarez P., Casey C., Deiss R., Letendre S., Marcotte T., Vaida F., et al. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug and Alcohol Dependence 2010, 106:154-163.
7. Copersino M.L., Serper M.R., Vadhan N., Goldberg B.R., Richarme D., Chou J.C., Stitzer M., et al. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Research 2004, 128:209-218.
8. Cox W.M., Brown M.A., Rowlands L.J. The effects of alcohol cue exposure on non-dependent drinkers' attentional bias for alcohol-related stimuli. Alcohol and Alcoholism 2003, 38:45-49.
9. Cox W.M., Hogan L.M., Kristian M.R., Race J.H. Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome. Drug and Alcohol Dependence 2002, 68:237-243.
10. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205-211.
11. Dackis C.A., Lynch K.G., Yu E., Samaha F.F., Kampman K.M., Cornish J.W., Rowan A., et al. Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug and Alcohol Dependence 2003, 70:29-37.
12. De La Garza R., Zorick T., London E.D., Newton T.F. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence 2010, 106:173-180.
13. Ersche K.D., Bullmore E.T., Craig K.J., Shabbir S.S., Abbott S., Müller U., Ooi C., et al. Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Archives of General Psychiatry 2010, 67:632-644.
14. Field M., Cox W.M. Attentional bias in addictive behaviors: A review of its development, causes, and consequences. Drug and Alcohol Dependence 2008, 97:1-20.
15. Field M., Mogg K., Bradley B.P. Eye movements to smoking-related cues: Effects of nicotine deprivation. Psychopharmacology (Berlin) 2004, 173:116-123.
16. Field M., Munafo M.R., Franken I.H. A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychological Bulletin 2009, 135:589-607.
17. Franken I.H., Kroon L.Y., Hendriks V.M. Influence of individual differences in craving and obsessive cocaine thoughts on attentional processes in cocaine abuse patients. Addictive Behaviours 2000, 25:99-102.
18. Franken I.H., Stam C.J., Hendriks V.M., van den Brink W. Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology (Berlin) 2003, 170:205-212.
19. Gill M., Haerich P., Westcott K., Godenick K.L., Tucker J.A. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: A double-blind randomized crossover study. Academic Emergency Medicine 2006, 13:158-165.
20. Gonzalez R. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence 2004, 76:181-190.
21. Greenhill L.L., Biederman J., Boellner S.W., Rugino T.A., Sangal R.B., Earl C.Q., Jiang J.G., et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:503-511.
22. Heinzerling K.G., Swanson A.N., Kim S., Cederblom L., Moe A., Ling W., Shoptaw S. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence 2010, 109:20-29.
23. Hermant J.F., Rambert F.A., Duteil J. Awakening properties of modafinil: Effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology (Berlin) 1991, 103:28-32.
24. Hester R., Dixon V., Garavan H. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug and Alcohol Dependence 2006, 81:251-257.
25. Hunter M.D., Ganesan V., Wilkinson I.D., Spence S.A. Impact of modafinil on prefrontal executive function in schizophrenia. American Journal of Psychiatry 2006, 163:2184-2186.
26. Iudicello J.E., Woods S.P., Vigil O., Cobb Scott J., Cherner M., Heaton R.K., Hampton Atkinson J., et al. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Journal of Clinical & Experimental Neuropsychology 2010, 32:704-718.
27. Kahbazi M., Ghoreishi A., Rahiminejad F., Mohammadi M.R., Kamalipour A., Akhondzadeh S. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Research 2009, 168:234-237.
28. Kalechstein A.D., Newton T.F., Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences 2003, 15:215-220.
29. Kalivas P.W., Volkow N.D. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry 2005, 162:1403-1413.
30. Lee B., London E.D., Poldrack R.A., Farahi J., Nacca A., Monterosso J.R., Mumford J.A., et al. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. Journal of Neuroscience 2009, 29:14734-14740.
31. Lee N., Pennay A., Harney A., Kenny P., Johns L. Psychostimulant withdrawal: Naturnal history and options for treatment 2007, Department of Human Services, Victoria, Australia.
32. London E., Berman S., Voytek B., Simon S., Mandelkern M., Monterosso J., Thompson P., et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biological Psychiatry 2005, 58:770-778.
33. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., Johnson R., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. Journal of Pharmacology and Experimental Therapeutics 2006, 319:561-569.
34. Marissen M.A., Franken I.H., Waters A.J., Blanken P., van den Brink W., Hendriks V.M. Attentional bias predicts heroin relapse following treatment. Addiction 2006, 101:1306-1312.
35. Mccann U.D., Kuwabara H., Kumar A., Palermo M., Abbey R., Brasic J., Ye W., et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2007, 62:91-100.
36. McElhiney M.C., Rabkin J.G., Rabkin R., Nunes E.V. Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: A pilot study. American Journal of Drug and Alcohol Abuse 2009, 35:34-37.
37. McGaugh J., Mancino M.J., Feldman Z., Chopra M.P., Gentry W.B., Cargile C., Oliveto A. Open-label pilot study of modafinil for methamphetamine dependence. Journal of Clinical Psychopharmacology 2009, 29:488-491.
38. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., White J.M. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005, 100:1320-1329.
39. McGregor C., Srisurapanont M., Mitchell A., Wickes W., White J.M. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual. Journal of Substance Abuse Treat 2008, 35:334-342.
40. McKetin R., Kelly E., McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence 2006, 85:198-204.
41. Mcketin R., McLaren J., Kelly E., Hall W., Hickman M. Estimating the number of regular and dependent methamphetamine users in Australia 2005, National Drug and Alcohol Research Centre, Sydney.
42. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006, 101:1473-1478.
43. McLaughlin D.F., McKenna H., Leslie J.C. The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. Journal of Psychiatric and Mental Health Nursing 2000, 7:435-441.
44. Meredith C., Jaffe C., Ang-Lee K. Implications of chronic methamphetamine use: A literature review. Harvard Review of Psychiatry 2005, 13:141-154.
45. Minzenberg M.J., Carter C.S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2007, 33:1-26.
46. Monterosso J.R., Ainslie G., Xu J., Cordova X., Domier C.P., London E.D. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Human Brain Mapping 2007, 28:383-393.
47. Monterosso J.R., Aron A.R., Cordova X., Xu J., London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug and Alcohol Dependence 2005, 79:273-277.
48. Morein-Zamir S., Turner D.C., Sahakian B.J. A review of the effects of modafinil on cognition in schizophrenia. Schizophrenia Bulletin 2007, 33:1298-1306.
49. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neurosciences 2003, 15:317-325.
50. Paulus M., Tapert S., Schuckit M. Activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry 2005, 62:761-768.
51. Randall D.C., Fleck N.L., Shneerson J.M., File S.E. The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacology, Biochemistry and Behavior 2004, 77:547-555.
52. Salo R., Nordahl T., Possin K., Leamon M., Gibson D. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research 2002, 111:65-74.
53. Salo R., Nordahl T.E., Moore C., Waters C., Natsuaki Y., Galloway G.P., Kile S., et al. A dissociation in attentional control: Evidence from methamphetamine dependence. Biological Psychiatry 2005, 57:310-313.
54. Salo R., Nordahl T.E., Possin K., Leamon M., Gibson D.R., Galloway G.P., Flynn N.M., et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research 2002, 111:65-74.
55. Schoenmakers T.M., Bruin M.D., Lux I.F., Goertz A.G., Kerkhof D.H.V., Wiers R.W. Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients. Drug and Alcohol Dependence 2010, 109:30-36.
56. Scott J.C., Woods S.P., Matt G.E., Meyer R.A., Heaton R.K., Atkinson J.H., Grant I. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review 2007, 17:275-297.
57. Shearer J., Darke S., Rodgers C., Slade T., van Beek I., Lewis J., Brady D., et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 2009, 104:224-233.
58. Shoptaw S.J., Kao U., Heinzerling K., Ling W. Treatment for amphetamine withdrawal. Cochrane Database System Review 2009, CD003021.
59. Simon S., Dacey J., Glynn S., Rawson R., Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. Journal of Substance Abuse Treatment 2004, 27:59-66.
60. Simon S.L., Dean A.C., Cordova X., Monterosso J.R., London E.D. Methamphetamine dependence and neuropsychological functioning: Evaluating change during early abstinence. Journal of Studies on Alcohol Drugs 2010, 71:335-344.
61. Simon S.L., Domier C.P., Sim T., Richardson K., Rawson R.A., Ling W. Cognitive performance of current methamphetamine and cocaine abusers. Journal of Addictive Diseases 2002, 21:61-74.
62. Streeter C.C., Terhune D.B., Whitfield T.H., Gruber S., Sarid-Segal O., Silveri M.M., Tzilos G., et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 2008, 33:827-836.
63. Thompson P.M. Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience 2004, 24:6028-6036.
64. Turner D.C., Clark L., Dowson J., Robbins T.W., Sahakian B.J. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 2004, 55:1031-1040.
65. Turner D.C., Clark L., Pomarol-Clotet E., McKenna P., Robbins T.W., Sahakian B.J. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 2004, 29:1363-1373.
66. Turner D.C., Robbins T.W., Clark L., Aron A.R., Dowson J., Sahakian B.J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berlin) 2003, 165:260-269.
67. 2007 world drug report 2007, United Nations Office on Drugs & Crime, Vienna International Centre, Vienna.
68. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience 2001, 21:9414-9418.
69. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. The American Journal of Psychiatry 2001, 158:377-382.
70. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., Wang G.J., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. Journal of the American Medical Association 2009, 301:1148-1154.
71. Waters A.J., Shiffman S., Sayette M.A., Paty J.A., Gwaltney C.J., Balabanis M.H. Attentional bias predicts outcome in smoking cessation. Health Psychology 2003, 22:378-387.
72. Westcott K.J. Modafinil, sleep deprivation, and cognitive function in military and medical settings. Military Medicine 2005, 170:333-335.